Dow Up 1.22% Nasdaq Up 2.00%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
5.72 Up 0.16(2.88%) May 24, 4:00PM EDT
Prev Close:5.56
Open:5.64
Bid:5.60 x 100
Ask:7.18 x 400
1y Target Est:11.50
Beta:2.06727
Earnings Date:Jul 29 - Aug 2 (Est.)
Day's Range:5.62 - 5.86
52wk Range:5.35 - 19.43
Volume:2,852,616
Avg Vol (3m):1,272,790
Market Cap:498.08M
P/E (ttm):N/A
EPS (ttm):-1.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 2.88%498.08M
SGENUp 1.40%5.60B
PFEUp 1.28%206.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-1.54
Quarterly EPS Est (Jun-16) :-0.39
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback